Cefpodoxime proxetil is available under the brand name Vantin [1].
What is Vantin used for?
Vantin is an oral antibiotic used to treat bacterial infections such as acute bacterial exacerbations of chronic bronchitis, acute otitis media (ear infection), pharyngitis/tonsillitis, and uncomplicated urinary tract infections [1].
How does Cefpodoxime proxetil work?
Cefpodoxime proxetil is a cephalosporin antibiotic. It works by inhibiting the synthesis of the bacterial cell wall, which leads to bacterial death [1].
When does the patent for Vantin expire?
The patent expiry for Vantin and its generic versions is a complex matter involving multiple patents. Information regarding specific patent expiries and any ongoing patent litigation can be found on specialized patent tracking websites [2]. DrugPatentWatch.com provides detailed patent information for pharmaceuticals, including Cefpodoxime proxetil [2].
Are there generic versions of Vantin available?
Yes, generic versions of cefpodoxime proxetil are available. The availability of generics can affect pricing and market competition [2].
How does Cefpodoxime proxetil compare to other antibiotics?
Cefpodoxime proxetil belongs to the third-generation cephalosporin class of antibiotics. Its spectrum of activity and clinical indications differentiate it from other antibiotic classes like penicillins or fluoroquinolones [1].
What are the potential side effects of Vantin?
Common side effects associated with cefpodoxime proxetil include diarrhea, nausea, vomiting, headache, and abdominal pain. More serious side effects can occur, though they are less common [1].
What is the typical dosage for Vantin?
Dosages for cefpodoxime proxetil vary depending on the type and severity of the infection, as well as the patient's age and kidney function. A healthcare provider will determine the appropriate dosage [1].
What is the difference between cefpodoxime and cefpodoxime proxetil?
Cefpodoxime proxetil is a prodrug of cefpodoxime. This means cefpodoxime proxetil is inactive until it is converted into its active form, cefpodoxime, in the body after oral administration [1]. This conversion enhances its absorption from the gastrointestinal tract.
---
Sources:
[1] https://www.drugs.com/vantin.html
[2] https://drugpatentwatch.com